Investigating the Prognostic Impact of NY-ESO-1 Expression and HLA Subtypes in Metastatic Synovial Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
ESMO Open 2024 Aug 16;9(8)103645, A Dufresne, S Pokras, A Meurgey, S Chabaud, M Toulmonde, E Bompas, A Le Cesne, YM Robin, F Duffaud, T Valentin, S El Zein, A Leroux, P Dubray-Longeras, N Firmin, G de Pinieux, S Noal, C Delfour, J Bollard, L Tonon, A Biette, N Gadot, V Attignon, M Jean-Denis, M Woessner, E Klohe, T Thayaparan, I Eleftheriadou, K Blouch, MJ Nathenson, JY BlayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.